TeamHealth has shut down a private merger offer from AmSurg Corp. TeamHealth is a hospital staffing company while AmSurg aids in running clinics and surgery centers, Bloomberg said. This was announced shortly after the latter has announced that it is engaging with TeamHealth on Tuesday, Reuters said. The offer was at USD5.3 billion at USD71.47 per share, of which TeamHealth is quick to retort that the offer is undervalued. It was noted that the offer was at a 36 percent premium of TeamHealth’s closing price on Monday.
Under the terms of the merger offer, the new company will assume the TeamHealth name and will continue to operate from its headquarters in Knoxville, Tennessee, Street Insider reports. Moreover, the Board of Directors will be filled with representatives from both companies, with AmSurg President and Chief Executive Officer Christopher Holden acting as the new CEO.
In a letter addressed to the members of TeamHealth’s Board, Holden said, “We are disappointed to learn that you chose not to engage with us based on what appears to be a very cursory analysis of our specific proposal and key deal terms.”
If the merger happened, the new company will have about 1,200 health-care facilities and 20,000 clinical workers in its stead, Amsurg said.


TSMC Japan's Second Fab to Produce 3nm Chips by 2028
OpenAI Executive Shake-Up Ahead of Anticipated 2026 IPO
SoftwareONE Posts 22.5% Revenue Surge in 2025 on Crayon Acquisition
First Western Ship Transits Strait of Hormuz Since Iran War Began
Microsoft's $10 Billion Japan Investment: AI Infrastructure and Data Sovereignty Push
KPMG UK Cuts 440 Audit Jobs Amid Low Attrition and Cooling Professional Services Demand
Elon Musk Ties SpaceX IPO Access to Mandatory Grok AI Subscriptions
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure
Annie Altman Amends Sexual Abuse Lawsuit Against OpenAI CEO Sam Altman
Jefferies Upgrades Sodexo to Buy With €55 Target After Historic CEO Appointment
Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook
SpaceX Eyes Historic IPO at $1.75 Trillion Valuation
Russell 1000 Companies Hit $2.2T Cash Record While Aggressively Reinvesting in Growth
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
Norma Group Posts Revenue Decline in 2025, Eyes Modest Recovery in 2026
McDonald's and Restaurant Brands International Face Headwinds Amid Iran Conflict and Rising Costs 



